Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $22.40 Consensus Target Price from Analysts

Key Points

• Cellebrite DI Ltd. (NASDAQ:CLBT) has received an average recommendation of "Buy" from analysts, with a target price of $22.40 over the next 12 months.
• Several institutional investors have increased their stakes in Cellebrite DI, including Northern Trust Corp, which lifted its position by 113.6% in the last quarter.
• Cellebrite DI reported earnings of $0.12 per share for the last quarter, surpassing analysts' expectations, with revenue growth of 18.4% year-over-year.

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given a consensus rating of "Buy" by the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $22.40.

CLBT has been the topic of a number of analyst reports. Wall Street Zen cut Cellebrite DI from a "buy" rating to a "hold" rating in a report on Saturday, September 13th. Needham & Company LLC decreased their price objective on Cellebrite DI from $24.00 to $18.00 and set a "buy" rating on the stock in a report on Thursday, August 14th. Finally, Lake Street Capital decreased their price objective on Cellebrite DI from $24.00 to $22.00 and set a "buy" rating on the stock in a report on Friday, August 15th.

Institutional Investors Weigh In On Cellebrite DI

Hedge funds have recently made changes to their positions in the business. Assetmark Inc. acquired a new stake in shares of Cellebrite DI during the first quarter worth $33,000. Signaturefd LLC boosted its holdings in Cellebrite DI by 68.3% in the second quarter. Signaturefd LLC now owns 2,019 shares of the company's stock valued at $32,000 after acquiring an additional 819 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in Cellebrite DI by 1,998.0% in the second quarter. PNC Financial Services Group Inc. now owns 2,098 shares of the company's stock valued at $34,000 after acquiring an additional 1,998 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in Cellebrite DI in the first quarter valued at $51,000. Finally, Virtus Advisers LLC acquired a new position in Cellebrite DI in the first quarter valued at $63,000. Institutional investors and hedge funds own 45.88% of the company's stock.

Cellebrite DI Price Performance

NASDAQ:CLBT traded up $0.61 during trading hours on Friday, reaching $17.87. 1,567,153 shares of the company traded hands, compared to its average volume of 1,818,868. The firm's 50-day moving average is $15.37 and its 200-day moving average is $16.94. The stock has a market cap of $4.28 billion, a P/E ratio of -23.51, a P/E/G ratio of 3.14 and a beta of 1.28. Cellebrite DI has a 1-year low of $13.10 and a 1-year high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last announced its earnings results on Thursday, August 14th. The company reported $0.12 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.01. The firm had revenue of $113.28 million for the quarter, compared to analysts' expectations of $112.33 million. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.Cellebrite DI's quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.10 EPS. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts predict that Cellebrite DI will post 0.3 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.